Due to the introduction of newer, more efficacious treatment options, there is a pressing
need for policy makers and public health officials to develop or adapt national hepatitis C …

Chronic hepatitis C virus (HCV) infection is a leading cause of liver related morbidity and
mortality. In many countries, there is a lack of comprehensive epidemiological data that are …

(HCV) and the availability of interferon (IFN)-free and soon ribavirin-free treatment regimens
of 12 weeks duration with sustained virologic response (SVR) rates of> 90% has stimulated …

AIM: To estimate the progression of the hepatitis C virus (HCV) epidemic and measure the
burden of HCV-related morbidity and mortality. METHODS: Age-and gender-defined cohorts …

Background: A significant number of patients infected with hepatitis C virus remain unaware
of their infection, as this is a silent disease for many years. Patients are frequently detected …

The recent history of the hepatitis C virus (HCV) subtypes 1a and 1b in the central region of
Argentina is hypothesized by phylogeographic reconstruction using coalescent based …

Hepatitis C virus (HCV) screening according to the year of birth is recommended is some
countries based on epidemiological data. The aim of this study was to analyze anti-HCV …

Hepatitis C virus (HCV) infection affects an estimated 71 million people worldwide. HCV is
classified into eight genotypes and> 70 subtypes. Determination of HCV genotype is …

Worldwide, more than 170 million people are chronically infected with the hepatitis C virus
(HCV) and every year die more than 350,000 people from HCV-related liver diseases …

Many studies have reported the use of the NS5B gene to subtype hepatitis C virus (HCV).
Other HCV genes, such as HCV-5′ UTR, Core (C) and E1, have also been used. In some …